DECISION SCIENCE FOR LIFE SCIENCES
Decision-making and execution discipline for leaders navigating product innovation, portfolio management, and M&A.
Clarity to choose. Confidence to act.
Built on 20 years of problem-solving and operator experience from lab to market.
THE DECISIONS
Business Evolution
For decisions that cannot be deferred, delegated, or reversed without material risk or cost.
Revenue impact
Strategy
Commercial Viability
Translate market insight into actionable asset roadmaps that create new value.
NPIs launched
Portfolio
Asset Prioritization
Maximize pipeline value through disciplined trade-offs in capital allocation.
Integrations
M&A
Due Diligence
Assess fit, operational viability, and execution risks before external commitment.
Global P&L impact across Sartorius, MilliporeSigma, and advisory.
CORE CAPABILITIES
Strengthen strategy
Verify high-value opportunities and characterize commercial and technical risks.
Anchor ambition.
Rationalize portfolio
Benchmark and prioritize pipeline assets to maximize capital efficiency.
Optimize returns.
Pressure-test thesis
Validate build, buy, partner, and scale assumptions and choices.
Accelerate growth.
ENGAGEMENT TRIGGERS
Strategy Calibration
Before deployment
Pressure test assumptions and response scenarios for capital intensive R&D programs, portfolio restructuring, or complex integrations.
Strengthen resilience.
Project Recovery
After disruption
Deliver objective oversight and intervention when programs stall, miss critical milestones, or repeatedly exceed budgets. Align and reset.
Restore progress.
Me-too pipelines
Delayed launches
Missed synergies
Competitor blue oceans
For life-science leaders making decisions that shape the next growth curve.